{"transactions":[{"id":994487,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-19T18:03:24.000Z","date":"2025-11-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":89127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option (\"Option\") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings."}],"balance_after":0,"derivative":{"exercise_price":33.64,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":89127},"source":{"system":"sec-edgar","filing":"0001193125-25-288424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/924717/000119312525288424/ownership.xml","form_type":"4"}},{"id":994486,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-19T18:03:24.000Z","date":"2025-11-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":84669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option (\"Option\") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings."}],"balance_after":0,"derivative":{"exercise_price":36.13,"expiration_date":"2029-11-30","underlying":"Common Stock","underlying_shares":84669},"source":{"system":"sec-edgar","filing":"0001193125-25-288424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/924717/000119312525288424/ownership.xml","form_type":"4"}},{"id":994485,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-19T18:03:24.000Z","date":"2025-11-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":73349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option (\"Option\") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings."}],"balance_after":0,"derivative":{"exercise_price":43.93,"expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":73349},"source":{"system":"sec-edgar","filing":"0001193125-25-288424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924717/000119312525288424/ownership.xml","form_type":"4"}},{"id":994484,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2025-11-19T18:03:24.000Z","date":"2025-11-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":74515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option (\"Option\") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings."}],"balance_after":0,"derivative":{"exercise_price":37.44,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":74515},"source":{"system":"sec-edgar","filing":"0001193125-25-288424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924717/000119312525288424/ownership.xml","form_type":"4"}},{"id":994483,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-19T18:03:24.000Z","date":"2025-11-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":62674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option (\"Option\") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings."}],"balance_after":0,"derivative":{"exercise_price":42,"expiration_date":"2026-11-26","underlying":"Common  Stock","underlying_shares":62674},"source":{"system":"sec-edgar","filing":"0001193125-25-288424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000119312525288424/ownership.xml","form_type":"4"}},{"id":994482,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-19T18:03:24.000Z","date":"2025-11-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option (\"Option\") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings."}],"balance_after":0,"derivative":{"exercise_price":56.63,"expiration_date":"2025-11-27","underlying":"Common Stock","underlying_shares":45073},"source":{"system":"sec-edgar","filing":"0001193125-25-288424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000119312525288424/ownership.xml","form_type":"4"}},{"id":994481,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-19T18:03:24.000Z","date":"2025-11-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":192056,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the \"Issuer\"), BCE Parent, LLC, (\"Parent\"), and BCE Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each share of the Issuer's common stock, par value $0.05 per share (\"Common Stock\"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the \"Merger Consideration\").  All outstanding restricted stock units (\"RSUs\") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-288424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000119312525288424/ownership.xml","form_type":"4"}},{"id":1340964,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common  Stock","published_at":"2024-12-06T16:46:00.000Z","date":"2024-12-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":4248,"price":39.91,"value":169537.68,"ownership":{"direct":true},"balance_after":192056,"source":{"system":"sec-edgar","filing":"0000950170-24-134181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000095017024134181/ownership.xml","form_type":"4"}},{"id":1345950,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-12-03T18:10:19.000Z","date":"2024-11-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":6470,"price":39.45,"value":255241.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 192 shares acquired through the Employee Stock Purchase Plan for the phase ending on 8/31/24"}],"balance_after":196304,"source":{"system":"sec-edgar","filing":"0000950170-24-132959","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000095017024132959/ownership.xml","form_type":"4"}},{"id":1424604,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-08-23T16:05:18.000Z","date":"2024-08-21","kind":"exercise","planned":false,"acquired":false,"shares":61017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":33.2,"expiration_date":"2024-11-28","underlying":"Common Stock","underlying_shares":61017},"source":{"system":"sec-edgar","filing":"0000950170-24-100171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000095017024100171/ownership.xml","form_type":"4"}},{"id":1424603,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:18.000Z","date":"2024-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":50569,"price":40.06,"value":2025794.14,"ownership":{"direct":true},"balance_after":202582,"source":{"system":"sec-edgar","filing":"0000950170-24-100171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000095017024100171/ownership.xml","form_type":"4"}},{"id":1424602,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-08-23T16:05:18.000Z","date":"2024-08-21","kind":"exercise","planned":false,"acquired":true,"shares":61017,"price":33.2,"value":2025764.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 464 shares acquired through the Employee Stock Purchase Plan for the phase ending on 2/29/24."}],"balance_after":253151,"source":{"system":"sec-edgar","filing":"0000950170-24-100171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000095017024100171/ownership.xml","form_type":"4"}},{"id":1720560,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-06T16:46:36.000Z","date":"2023-12-04","kind":"grant","planned":false,"acquired":true,"shares":89127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award vests in four equal installments on each of the first four anniversaries of the December 4, 2023 grant date."}],"balance_after":89127,"derivative":{"exercise_price":33.64,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":89127},"source":{"system":"sec-edgar","filing":"0001209191-23-057622","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919123057622/doc4.xml","form_type":"4"}},{"id":1720559,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-06T16:46:36.000Z","date":"2023-12-04","kind":"grant","planned":false,"acquired":true,"shares":27942,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":191670,"source":{"system":"sec-edgar","filing":"0001209191-23-057622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919123057622/doc4.xml","form_type":"4"}},{"id":1724445,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-04T17:09:11.000Z","date":"2023-11-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3703,"price":32.82,"value":121532.46,"ownership":{"direct":true},"balance_after":163728,"source":{"system":"sec-edgar","filing":"0001209191-23-057265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919123057265/doc4.xml","form_type":"4"}},{"id":1724444,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-04T17:09:11.000Z","date":"2023-11-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2768,"price":32.82,"value":90845.76,"ownership":{"direct":true},"balance_after":167431,"source":{"system":"sec-edgar","filing":"0001209191-23-057265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919123057265/doc4.xml","form_type":"4"}},{"id":1724443,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-12-04T17:09:11.000Z","date":"2023-11-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2639,"price":32.82,"value":86611.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 647 shares acquired through the Employee Stock Purchase Plan for the phase ending on 2/28/23 and 127 shares acquired for the phase ending on 8/31/23 ."}],"balance_after":170199,"source":{"system":"sec-edgar","filing":"0001209191-23-057265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919123057265/doc4.xml","form_type":"4"}},{"id":2099031,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee  Stock Option (right to buy)","published_at":"2022-12-02T18:50:12.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":84669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award vests in four equal installments on each of the first four anniversaries of the November 30, 2022 grant date."}],"balance_after":84669,"derivative":{"exercise_price":36.13,"expiration_date":"2029-11-30","underlying":"Common Stock","underlying_shares":84669},"source":{"system":"sec-edgar","filing":"0001209191-22-059495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919122059495/doc4.xml","form_type":"4"}},{"id":2099030,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-12-02T18:50:12.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":24356,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":172064,"source":{"system":"sec-edgar","filing":"0001209191-22-059495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919122059495/doc4.xml","form_type":"4"}},{"id":2099029,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-12-02T18:50:12.000Z","date":"2022-11-30","kind":"tax_withholding","acquired":false,"shares":2768,"price":36.13,"value":100007.84,"ownership":{"direct":true},"balance_after":147708,"source":{"system":"sec-edgar","filing":"0001209191-22-059495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919122059495/doc4.xml","form_type":"4"}},{"id":2099028,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-12-02T18:50:12.000Z","date":"2022-11-30","kind":"tax_withholding","acquired":false,"shares":2639,"price":36.13,"value":95347.07,"ownership":{"direct":true},"balance_after":150476,"source":{"system":"sec-edgar","filing":"0001209191-22-059495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919122059495/doc4.xml","form_type":"4"}},{"id":2102813,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-11-29T17:35:08.000Z","date":"2022-11-25","kind":"tax_withholding","acquired":false,"shares":2172,"price":36.02,"value":78235.44,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 246 shares acquired through the Employee Stock Purchase Plan for the phase ending 8/31/22."}],"balance_after":153115,"source":{"system":"sec-edgar","filing":"0001209191-22-058983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919122058983/doc4.xml","form_type":"4"}},{"id":2305814,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-04-05T17:31:09.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":100,"price":45.55,"value":4555.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."}],"balance_after":155041,"source":{"system":"sec-edgar","filing":"0001209191-22-023199","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919122023199/doc4.xml","form_type":"4"}},{"id":2305813,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common  Stock","published_at":"2022-04-05T17:31:09.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":3900,"price":44.9742,"value":175399.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 3,900 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on April 1, 2022 with sale prices ranging from $44.49 to $45.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 308 shares acquired through the Employee Stock Purchase Plan for the phase ending 2/28/22."}],"balance_after":155141,"source":{"system":"sec-edgar","filing":"0001209191-22-023199","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919122023199/doc4.xml","form_type":"4"}},{"id":2489566,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-02T15:07:45.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":73349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award vests in four equal installments on each of the first four anniversaries of the November 30, 2021 grant date."}],"balance_after":73349,"derivative":{"exercise_price":43.93,"expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":73349},"source":{"system":"sec-edgar","filing":"0001209191-21-067517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121067517/doc4.xml","form_type":"4"}},{"id":2489565,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common  Stock","published_at":"2021-12-02T15:07:45.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":18210,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158733,"source":{"system":"sec-edgar","filing":"0001209191-21-067517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121067517/doc4.xml","form_type":"4"}},{"id":2489564,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-12-02T15:07:45.000Z","date":"2021-11-30","kind":"tax_withholding","acquired":false,"shares":2639,"price":43.93,"value":115931.27,"ownership":{"direct":true},"balance_after":140523,"source":{"system":"sec-edgar","filing":"0001209191-21-067517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121067517/doc4.xml","form_type":"4"}},{"id":2493686,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-29T16:29:16.000Z","date":"2021-11-27","kind":"tax_withholding","acquired":false,"shares":1477,"price":45.77,"value":67602.29,"ownership":{"direct":true},"balance_after":143162,"source":{"system":"sec-edgar","filing":"0001209191-21-066992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121066992/doc4.xml","form_type":"4"}},{"id":2493685,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-29T16:29:16.000Z","date":"2021-11-25","kind":"tax_withholding","acquired":false,"shares":2172,"price":47.85,"value":103930.2,"ownership":{"direct":true},"balance_after":144639,"source":{"system":"sec-edgar","filing":"0001209191-21-066992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121066992/doc4.xml","form_type":"4"}},{"id":2529737,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T17:49:21.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":200,"price":55.245,"value":11049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 200 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 1, 2021 with sale prices ranging from $55.23 to $55.26 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":146811,"source":{"system":"sec-edgar","filing":"0001209191-21-062477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121062477/doc4.xml","form_type":"4"}},{"id":2529736,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-02T17:49:21.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":5800,"price":54.6302,"value":316855.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,800 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 1, 2021 with sale prices ranging from $54.23 to $55.17 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":147011,"source":{"system":"sec-edgar","filing":"0001209191-21-062477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121062477/doc4.xml","form_type":"4"}},{"id":2550103,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-10-05T16:01:21.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":500,"price":56.533,"value":28266.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 500 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on October 1, 2021 with sale prices ranging from $56.45 to $56.59 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":152811,"source":{"system":"sec-edgar","filing":"0001209191-21-059344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121059344/doc4.xml","form_type":"4"}},{"id":2550102,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-10-05T16:01:21.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":5500,"price":55.9692,"value":307830.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,500 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on October 1, 2021 with sale prices ranging from $55.415 to $56.39 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":153311,"source":{"system":"sec-edgar","filing":"0001209191-21-059344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121059344/doc4.xml","form_type":"4"}},{"id":2566667,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-17T16:04:52.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":4970,"price":57.3393,"value":284976.321,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average price of 4,970 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on September 15, 2021 with sale prices ranging from $57.16 to $57.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":158811,"source":{"system":"sec-edgar","filing":"0001209191-21-056609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121056609/doc4.xml","form_type":"4"}},{"id":2566666,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-09-17T16:04:52.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":1030,"price":56.6824,"value":58382.872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 1,030 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on September 15, 2021 with sale prices ranging from $56.13 to $57.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 98 shares acquired through the Employee Stock Purchase Plan for the phase ending August 31, 2021."}],"balance_after":163781,"source":{"system":"sec-edgar","filing":"0001209191-21-056609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121056609/doc4.xml","form_type":"4"}},{"id":2816109,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-03-03T18:12:43.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":999,"price":52.6731,"value":52620.4269,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average price of 999 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on March 1, 2021 with sale prices ranging from $52.52 to $52.92 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":164713,"source":{"system":"sec-edgar","filing":"0001209191-21-017200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121017200/doc4.xml","form_type":"4"}},{"id":2816108,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-03-03T18:12:43.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3001,"price":51.8623,"value":155638.7623,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 3,001 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on March 1, 2021 with sale prices ranging from $51.50 to $52.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 459 shares acquired through the Employee Stock Purchase Plan for the phase ending 02/26/2021."}],"balance_after":165712,"source":{"system":"sec-edgar","filing":"0001209191-21-017200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121017200/doc4.xml","form_type":"4"}},{"id":2860485,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-16T16:52:00.000Z","date":"2021-02-11","kind":"exercise","acquired":false,"shares":44779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":23.95,"expiration_date":"2023-11-30","underlying":"Common Stock","underlying_shares":44779},"source":{"system":"sec-edgar","filing":"0001209191-21-010801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121010801/doc4.xml","form_type":"4"}},{"id":2860484,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-16T16:52:00.000Z","date":"2021-02-11","kind":"exercise","acquired":false,"shares":27174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":20.25,"expiration_date":"2022-12-17","underlying":"Common Stock","underlying_shares":27174},"source":{"system":"sec-edgar","filing":"0001209191-21-010801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121010801/doc4.xml","form_type":"4"}},{"id":2860483,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-16T16:52:00.000Z","date":"2021-02-11","kind":"exercise","acquired":false,"shares":10311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":21.03,"expiration_date":"2021-12-02","underlying":"Common Stock","underlying_shares":10311},"source":{"system":"sec-edgar","filing":"0001209191-21-010801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121010801/doc4.xml","form_type":"4"}},{"id":2860482,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-16T16:52:00.000Z","date":"2021-02-11","kind":"tax_withholding","acquired":false,"shares":56152,"price":53.86,"value":3024346.72,"ownership":{"direct":true},"balance_after":168254,"source":{"system":"sec-edgar","filing":"0001209191-21-010801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121010801/doc4.xml","form_type":"4"}},{"id":2860481,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-16T16:52:00.000Z","date":"2021-02-11","kind":"exercise","acquired":true,"shares":44779,"price":23.95,"value":1072457.05,"ownership":{"direct":true},"balance_after":224406,"source":{"system":"sec-edgar","filing":"0001209191-21-010801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121010801/doc4.xml","form_type":"4"}},{"id":2860480,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-16T16:52:00.000Z","date":"2021-02-11","kind":"exercise","acquired":true,"shares":27174,"price":20.25,"value":550273.5,"ownership":{"direct":true},"balance_after":179627,"source":{"system":"sec-edgar","filing":"0001209191-21-010801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121010801/doc4.xml","form_type":"4"}},{"id":2860479,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-16T16:52:00.000Z","date":"2021-02-11","kind":"exercise","acquired":true,"shares":10311,"price":21.03,"value":216840.33,"ownership":{"direct":true},"balance_after":152453,"source":{"system":"sec-edgar","filing":"0001209191-21-010801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121010801/doc4.xml","form_type":"4"}},{"id":2883230,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-03T16:14:41.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":157,"price":45.54,"value":7149.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020."}],"balance_after":142142,"source":{"system":"sec-edgar","filing":"0001209191-21-007223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121007223/doc4.xml","form_type":"4"}},{"id":2883229,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-03T16:14:41.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":2843,"price":44.7672,"value":127273.1496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 2,843 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2021 with sale prices ranging from $44.50 to $45.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":142299,"source":{"system":"sec-edgar","filing":"0001209191-21-007223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121007223/doc4.xml","form_type":"4"}},{"id":2917102,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-06T16:25:27.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2000,"price":43.9628,"value":87925.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 2,000 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on January 4, 2021 with sale prices ranging from $43.485 to $44.24 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":145142,"source":{"system":"sec-edgar","filing":"0001209191-21-002066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919121002066/doc4.xml","form_type":"4"}},{"id":2961618,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-02T17:12:57.000Z","date":"2020-11-30","kind":"grant","acquired":true,"shares":74515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award vests in four equal installments on each of the first four anniversaries of the November 30, 2020 grant date."}],"balance_after":74515,"derivative":{"exercise_price":37.44,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":74515},"source":{"system":"sec-edgar","filing":"0001209191-20-061225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120061225/doc4.xml","form_type":"4"}},{"id":2961617,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-12-02T17:12:57.000Z","date":"2020-11-30","kind":"grant","acquired":true,"shares":17361,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":147142,"source":{"system":"sec-edgar","filing":"0001209191-20-061225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120061225/doc4.xml","form_type":"4"}},{"id":2964674,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-11-30T19:19:53.000Z","date":"2020-11-28","kind":"tax_withholding","acquired":false,"shares":1969,"price":38.36,"value":75530.84,"ownership":{"direct":true},"balance_after":129781,"source":{"system":"sec-edgar","filing":"0001209191-20-060803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120060803/doc4.xml","form_type":"4"}},{"id":2964673,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-11-30T19:19:53.000Z","date":"2020-11-27","kind":"tax_withholding","acquired":false,"shares":1477,"price":38.36,"value":56657.72,"ownership":{"direct":true},"balance_after":131750,"source":{"system":"sec-edgar","filing":"0001209191-20-060803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120060803/doc4.xml","form_type":"4"}},{"id":2964672,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-11-30T19:19:53.000Z","date":"2020-11-25","kind":"tax_withholding","acquired":false,"shares":2172,"price":38.93,"value":84555.96,"ownership":{"direct":true},"balance_after":133227,"source":{"system":"sec-edgar","filing":"0001209191-20-060803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120060803/doc4.xml","form_type":"4"}},{"id":3040055,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-09-03T17:06:40.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":3000,"price":45.0688,"value":135206.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 3,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on September 1, 2020 with sale prices ranging from $44.58 to $45.355 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 257 shares acquired through the Employee Stock Purchase Plan for the phase ending August 31, 2020."}],"balance_after":135399,"source":{"system":"sec-edgar","filing":"0001209191-20-049456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120049456/doc4.xml","form_type":"4"}},{"id":3064233,"issuer":{"id":5507,"kind":"organization","name":"NVE CORP /NEW/","symbol":"NVEC"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2020-08-10T10:26:11.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Option granted automatically on Mr. Maharaj's reelection to NVE's Board of Directors"}],"balance_after":7000,"derivative":{"exercise_price":57.24,"exercise_date":"2020-08-06","expiration_date":"2030-08-06","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000724910-20-000036","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724910/000072491020000036/primary_doc.xml","form_type":"4"}},{"id":3068383,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-08-05T16:28:17.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":3000,"price":47.4446,"value":142333.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 3,000 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on August 3, 2020 with sale prices ranging from $47.015 to $47.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":138142,"source":{"system":"sec-edgar","filing":"0001209191-20-045109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120045109/doc4.xml","form_type":"4"}},{"id":3089638,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-07-06T18:10:17.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":2000,"price":43.0183,"value":86036.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 2,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on July 1, 2020 with sale prices ranging from $42.62 to $43.27 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 257 shares acquired through the Employee Stock Purchase Plan for the phase ending 02/28/20."}],"balance_after":141142,"source":{"system":"sec-edgar","filing":"0001179110-20-008058","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000117911020008058/edgar.xml","form_type":"4"}},{"id":3319727,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-01-06T21:32:02.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":702,"price":41.0841,"value":28841.0382,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 702 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on January 2, 2020 with sale prices ranging from $40.77 to $41.59 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":142885,"source":{"system":"sec-edgar","filing":"0001209191-20-002178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120002178/doc4.xml","form_type":"4"}},{"id":3353096,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-12-04T16:34:31.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":730,"price":40.7437,"value":29742.901,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 730 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 2, 2019 with sale prices ranging from $40.725 to $40.88 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":143587,"source":{"system":"sec-edgar","filing":"0001209191-19-059071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119059071/doc4.xml","form_type":"4"}},{"id":3353095,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-12-04T16:34:31.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":4270,"price":40.3303,"value":172210.381,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 4,270 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 2, 2019 with sale prices ranging from $39.725 to $40.67 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":144317,"source":{"system":"sec-edgar","filing":"0001209191-19-059071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119059071/doc4.xml","form_type":"4"}},{"id":3356209,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-12-02T16:08:19.000Z","date":"2019-11-30","kind":"tax_withholding","acquired":false,"shares":1079,"price":41.04,"value":44282.16,"ownership":{"direct":true},"balance_after":148587,"source":{"system":"sec-edgar","filing":"0001209191-19-058510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119058510/doc4.xml","form_type":"4"}},{"id":3356208,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-12-02T16:08:19.000Z","date":"2019-11-28","kind":"tax_withholding","acquired":false,"shares":1969,"price":40.89,"value":80512.41,"ownership":{"direct":true},"balance_after":149666,"source":{"system":"sec-edgar","filing":"0001209191-19-058510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119058510/doc4.xml","form_type":"4"}},{"id":3356207,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-12-02T16:08:19.000Z","date":"2019-11-27","kind":"tax_withholding","acquired":false,"shares":1477,"price":40.89,"value":60394.53,"ownership":{"direct":true},"balance_after":151635,"source":{"system":"sec-edgar","filing":"0001209191-19-058510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119058510/doc4.xml","form_type":"4"}},{"id":3358003,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-27T15:26:19.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":62674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vests in four equal installments on each of the first four anniversaries of the November 25, 2019 grant date."}],"balance_after":62674,"derivative":{"exercise_price":42,"expiration_date":"2026-11-25","underlying":"Common Stock","underlying_shares":62674},"source":{"system":"sec-edgar","filing":"0001209191-19-058304","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119058304/doc4.xml","form_type":"4"}},{"id":3358002,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-11-27T15:26:19.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":14285,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":153112,"source":{"system":"sec-edgar","filing":"0001209191-19-058304","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119058304/doc4.xml","form_type":"4"}},{"id":3358001,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-11-27T15:26:19.000Z","date":"2019-11-25","kind":"tax_withholding","acquired":false,"shares":9367,"price":42,"value":393414.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy taxes incident to vesting of performance share award."}],"balance_after":138827,"source":{"system":"sec-edgar","filing":"0001209191-19-058304","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119058304/doc4.xml","form_type":"4"}},{"id":3358000,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-11-27T15:26:19.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":20541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance shares awarded under long-term incentive plan based on performance during three-year period ended September 30, 2019."}],"balance_after":148194,"source":{"system":"sec-edgar","filing":"0001209191-19-058304","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119058304/doc4.xml","form_type":"4"}},{"id":3380842,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-11-05T17:11:33.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":500,"price":41.288,"value":20644.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 500 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2019 with sale prices ranging from $40.96 to $41.77 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":127653,"source":{"system":"sec-edgar","filing":"0001209191-19-055278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119055278/doc4.xml","form_type":"4"}},{"id":3380841,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-11-05T17:11:33.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":4500,"price":40.5152,"value":182318.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 4,500 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2019 with sale prices ranging from $39.95 to $40.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":128153,"source":{"system":"sec-edgar","filing":"0001209191-19-055278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119055278/doc4.xml","form_type":"4"}},{"id":3399355,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-10-03T16:16:55.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":300,"price":46.1417,"value":13842.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 300 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2019 with sale prices ranging from $46.06 to $46.305 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":132653,"source":{"system":"sec-edgar","filing":"0001209191-19-052142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119052142/doc4.xml","form_type":"4"}},{"id":3399354,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-10-03T16:16:55.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":4700,"price":45.4585,"value":213654.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 4,700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2019 with sale prices ranging from $45.01 to $45.945 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":132953,"source":{"system":"sec-edgar","filing":"0001209191-19-052142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119052142/doc4.xml","form_type":"4"}},{"id":3422347,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-09-05T16:11:55.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":5000,"price":45.9529,"value":229764.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on September 3, 2019 with sale prices ranging from $45.61 to $46.60 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 448 shares acquired through the Employee Stock Purchase Plan for the phase ending 8/30/19."}],"balance_after":137653,"source":{"system":"sec-edgar","filing":"0001209191-19-048488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119048488/doc4.xml","form_type":"4"}},{"id":3447769,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-05T16:12:30.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":2770,"price":46.7816,"value":129585.032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 2,770 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 1, 2019 with sale prices ranging from $46.68 to $47.31 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":142205,"source":{"system":"sec-edgar","filing":"0001209191-19-044510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119044510/doc4.xml","form_type":"4"}},{"id":3447768,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-05T16:12:30.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":2230,"price":46.1495,"value":102913.385,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 2,230 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 1, 2019 with sale prices ranging from $45.62 to $46.58 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":144975,"source":{"system":"sec-edgar","filing":"0001209191-19-044510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119044510/doc4.xml","form_type":"4"}},{"id":3450198,"issuer":{"id":5507,"kind":"organization","name":"NVE CORP /NEW/","symbol":"NVEC"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2019-08-02T20:32:57.000Z","date":"2019-08-01","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Option granted automatically on Mr. Maharaj's reelection to NVE's Board of Directors"}],"balance_after":6000,"derivative":{"exercise_price":67.65,"exercise_date":"2019-08-01","expiration_date":"2029-08-01","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000724910-19-000033","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724910/000072491019000033/primary_doc.xml","form_type":"4"}},{"id":3469179,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-07-03T16:17:15.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":3030,"price":42.9738,"value":130210.614,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 3,030 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on July 1, 2019 with sale prices ranging from $42.71 to $43.34 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":147205,"source":{"system":"sec-edgar","filing":"0001209191-19-041074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119041074/doc4.xml","form_type":"4"}},{"id":3469178,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-07-03T16:17:15.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":1970,"price":42.176,"value":83086.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 1,970 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on July 1, 2019 with sale prices ranging from $41.715 to $42.705 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":150235,"source":{"system":"sec-edgar","filing":"0001209191-19-041074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119041074/doc4.xml","form_type":"4"}},{"id":3501180,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-06-05T16:46:53.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":5000,"price":40.9479,"value":204739.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 3, 2019 with sale prices ranging from $40.07 to $40.845 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":152205,"source":{"system":"sec-edgar","filing":"0001209191-19-034770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119034770/doc4.xml","form_type":"4"}},{"id":3540782,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-05-03T16:16:55.000Z","date":"2019-05-01","kind":"sale","acquired":false,"shares":5000,"price":42.678,"value":213390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 1, 2019 with sale prices ranging from $42.35 to $43.255 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":157205,"source":{"system":"sec-edgar","filing":"0001209191-19-027340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119027340/doc4.xml","form_type":"4"}},{"id":3566370,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-04-03T15:56:30.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":5000,"price":42.8996,"value":214498.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on April 1, 2019 with sale prices ranging from $42.62 to $43.34 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 171 shares acquired through the Employee Stock Purchase Plan for the phase ending 2/28/19."}],"balance_after":162205,"source":{"system":"sec-edgar","filing":"0001209191-19-023059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119023059/doc4.xml","form_type":"4"}},{"id":3675585,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T17:30:47.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":100,"price":56.36,"value":5636.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."}],"balance_after":167034,"source":{"system":"sec-edgar","filing":"0001209191-19-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119007428/doc4.xml","form_type":"4"}},{"id":3675584,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T17:30:47.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":300,"price":55.53,"value":16659.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the weighted average price of 300 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $54.885 to $55.865 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":167134,"source":{"system":"sec-edgar","filing":"0001209191-19-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119007428/doc4.xml","form_type":"4"}},{"id":3675583,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T17:30:47.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":840,"price":54.049,"value":45401.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Reflects the weighted average price of 840 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $53.805 to $54.33 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":167434,"source":{"system":"sec-edgar","filing":"0001209191-19-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119007428/doc4.xml","form_type":"4"}},{"id":3675582,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T17:30:47.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":925,"price":53.0502,"value":49071.435,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the weighted average price of 925 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $52.75 to $53.675 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":168274,"source":{"system":"sec-edgar","filing":"0001209191-19-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119007428/doc4.xml","form_type":"4"}},{"id":3675581,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T17:30:47.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":668,"price":51.8681,"value":34647.8908,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average price of 668 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $51.561 to $52.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":169199,"source":{"system":"sec-edgar","filing":"0001209191-19-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119007428/doc4.xml","form_type":"4"}},{"id":3675580,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T17:30:47.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":700,"price":74.1043,"value":51873.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average price of 700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $74.00 to $74.29 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":169867,"source":{"system":"sec-edgar","filing":"0001209191-19-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119007428/doc4.xml","form_type":"4"}},{"id":3675579,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T17:30:47.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":200,"price":72.75,"value":14550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 200 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $72.56 to $72.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":170567,"source":{"system":"sec-edgar","filing":"0001209191-19-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119007428/doc4.xml","form_type":"4"}},{"id":3675578,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-02-05T17:30:47.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":4100,"price":72.0366,"value":295350.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 4,100 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $71.38 to $72.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":170767,"source":{"system":"sec-edgar","filing":"0001209191-19-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119007428/doc4.xml","form_type":"4"}},{"id":3705742,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-01-04T16:50:44.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":100,"price":46.83,"value":4683.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."}],"balance_after":174867,"source":{"system":"sec-edgar","filing":"0001209191-19-002038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119002038/doc4.xml","form_type":"4"}},{"id":3705741,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-01-04T16:50:44.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":4900,"price":46.2045,"value":226402.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 4,900 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on January 2, 2019 with sale prices ranging from $45.76 to $46.67 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":174967,"source":{"system":"sec-edgar","filing":"0001209191-19-002038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119002038/doc4.xml","form_type":"4"}},{"id":3744943,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-12-04T16:20:38.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":896,"price":60.3786,"value":54099.2256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average price of 896 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 3, 2018 with sale prices ranging from $60.24 to $60.68 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":179867,"source":{"system":"sec-edgar","filing":"0001209191-18-060854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060854/doc4.xml","form_type":"4"}},{"id":3744942,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-12-04T16:20:38.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":1557,"price":59.5725,"value":92754.3825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 1,557 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 3, 2018 with sale prices ranging from $59.205 to $60.16 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":180763,"source":{"system":"sec-edgar","filing":"0001209191-18-060854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060854/doc4.xml","form_type":"4"}},{"id":3744941,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-12-04T16:20:38.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":2547,"price":58.8504,"value":149891.9688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 2,547 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 3, 2018 with sale prices ranging from $58.21 to $59.17 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":182320,"source":{"system":"sec-edgar","filing":"0001209191-18-060854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060854/doc4.xml","form_type":"4"}},{"id":3744940,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-12-04T16:20:38.000Z","date":"2018-11-30","kind":"tax_withholding","acquired":false,"shares":1079,"price":60.59,"value":65376.61,"ownership":{"direct":true},"balance_after":184867,"source":{"system":"sec-edgar","filing":"0001209191-18-060854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060854/doc4.xml","form_type":"4"}},{"id":3749665,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-11-29T16:09:50.000Z","date":"2018-11-27","kind":"grant","acquired":true,"shares":45073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vests in four equal installments on each of the first four anniversaries of the November 27, 2018 grant date."}],"balance_after":45073,"derivative":{"exercise_price":56.63,"expiration_date":"2025-11-27","underlying":"Common Stock","underlying_shares":45073},"source":{"system":"sec-edgar","filing":"0001209191-18-060218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060218/doc4.xml","form_type":"4"}},{"id":3749664,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-29T16:09:50.000Z","date":"2018-11-28","kind":"tax_withholding","acquired":false,"shares":1969,"price":60.06,"value":118258.14,"ownership":{"direct":true},"balance_after":185946,"source":{"system":"sec-edgar","filing":"0001209191-18-060218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060218/doc4.xml","form_type":"4"}},{"id":3749663,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-29T16:09:50.000Z","date":"2018-11-27","kind":"tax_withholding","acquired":false,"shares":10834,"price":56.63,"value":613529.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy taxes incident to vesting of performance share award."}],"balance_after":187915,"source":{"system":"sec-edgar","filing":"0001209191-18-060218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060218/doc4.xml","form_type":"4"}},{"id":3749662,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-29T16:09:50.000Z","date":"2018-11-27","kind":"grant","acquired":true,"shares":23758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in connection with the vesting of a performance share award under long-term incentive plan based on performance during three-year period ended September 30, 2018."}],"balance_after":198749,"source":{"system":"sec-edgar","filing":"0001209191-18-060218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060218/doc4.xml","form_type":"4"}},{"id":3749661,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-29T16:09:50.000Z","date":"2018-11-27","kind":"grant","acquired":true,"shares":9712,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":174991,"source":{"system":"sec-edgar","filing":"0001209191-18-060218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118060218/doc4.xml","form_type":"4"}},{"id":3774800,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-05T16:38:16.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":807,"price":62.6427,"value":50552.6589,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 807 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2018 with sale prices ranging from $62.51 to $63.085 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":165279,"source":{"system":"sec-edgar","filing":"0001209191-18-057190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118057190/doc4.xml","form_type":"4"}},{"id":3774799,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":72916,"kind":"person","name":"Maharaj Gary R","position":1,"cik":"0001508798","reported_name":"Maharaj Gary R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-05T16:38:16.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":4193,"price":62.1251,"value":260490.5443,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 4,193 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 1, 2018 with sale prices ranging from $61.50 to $62.43 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":166086,"source":{"system":"sec-edgar","filing":"0001209191-18-057190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118057190/doc4.xml","form_type":"4"}}],"next_cursor":"2018-11-05T16:38:16.000000Z,3774799"}